勃起不全の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Erectile Dysfunction Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8102235)・商品コード:GIR8102235
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年10月12日(※2024年版があります。お問い合わせください)
・ページ数:154
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、勃起不全の世界市場について調べ、まとめました。種類別セグメントは、ED薬、EDデバイス等、用途別セグメントは、先天性患者、病理学的患者等に区分しました。勃起不全の世界市場概観、メーカー動向、メーカー別勃起不全シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・勃起不全の市場概観
・勃起不全のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・勃起不全のメーカー別販売動向、市場シェア、市場集中度、競争動向
・勃起不全の世界市場規模
・勃起不全の北米市場分析(アメリカ、カナダ、メキシコ等)
・勃起不全のアメリカ市場規模推移
・勃起不全のカナダ市場規模推移
・勃起不全のメキシコ市場規模推移
・勃起不全のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・勃起不全のドイツ市場規模推移
・勃起不全のイギリス市場規模推移
・勃起不全のロシア市場規模推移
・勃起不全のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・勃起不全の日本市場規模推移
・勃起不全の中国市場規模推移
・勃起不全の韓国市場規模推移
・勃起不全のインド市場規模推移
・勃起不全の東南アジア市場規模推移
・勃起不全の南米市場分析(ブラジル、アルゼンチン等)
・勃起不全の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・勃起不全の種類別分析/市場規模推移(ED薬、EDデバイス)
・勃起不全の用途別分析/市場規模推移(先天性患者、病理学的患者)
・勃起不全の市場予測(地域別予測、種類別予測、用途別予測)
・勃起不全の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels.

Scope of the Report:

This report studies the Erectile Dysfunction market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Erectile Dysfunction market by product type and applications/end industries.

The ED drugs segment led the market and accounted for almost 80% of the market share in terms of revenue.

In terms of geography, the Americas dominated the global erectile dysfunction market and is expected to hold close to 50% of the market share.

The global Erectile Dysfunction market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Erectile Dysfunction.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Eli Lilly

Pfizer

Bayer

Boston Scientific

Coloplast

Apricus Biosciences

Cristalia Produtos Quimicos Farmaceuticos

Dong-A Socio

Endo Pharmaceuticals

Futura Medical

Meda Pharmaceuticals

Promedon

SK Chemical

Teva Pharmaceuticals

Vivus

Zephyr Surgical Implants (ZSI)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

ED Drugs

ED Devices

Market Segment by Applications, can be divided into

Congenital Patients

Pathological Patients

【レポートの目次】

Table of Contents

1 Erectile Dysfunction Market Overview

1.1 Product Overview and Scope of Erectile Dysfunction

1.2 Classification of Erectile Dysfunction by Types

1.2.1 Global Erectile Dysfunction Revenue Comparison by Types (2017-2023)

1.2.2 Global Erectile Dysfunction Revenue Market Share by Types in 2017

1.2.3 ED Drugs

1.2.4 ED Devices

1.3 Global Erectile Dysfunction Market by Application

1.3.1 Global Erectile Dysfunction Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Congenital Patients

1.3.3 Pathological Patients

1.4 Global Erectile Dysfunction Market by Regions

1.4.1 Global Erectile Dysfunction Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Erectile Dysfunction Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Erectile Dysfunction Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Erectile Dysfunction Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Erectile Dysfunction Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Erectile Dysfunction Status and Prospect (2013-2023)

1.5 Global Market Size of Erectile Dysfunction (2013-2023)

2 Manufacturers Profiles

2.1 Eli Lilly

2.1.1 Business Overview

2.1.2 Erectile Dysfunction Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Eli Lilly Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.2 Pfizer

2.2.1 Business Overview

2.2.2 Erectile Dysfunction Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Pfizer Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.3 Bayer

2.3.1 Business Overview

2.3.2 Erectile Dysfunction Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Bayer Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.4 Boston Scientific

2.4.1 Business Overview

2.4.2 Erectile Dysfunction Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Boston Scientific Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.5 Coloplast

2.5.1 Business Overview

2.5.2 Erectile Dysfunction Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Coloplast Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.6 Apricus Biosciences

2.6.1 Business Overview

2.6.2 Erectile Dysfunction Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Apricus Biosciences Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.7 Cristalia Produtos Quimicos Farmaceuticos

2.7.1 Business Overview

2.7.2 Erectile Dysfunction Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.8 Dong-A Socio

2.8.1 Business Overview

2.8.2 Erectile Dysfunction Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Dong-A Socio Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.9 Endo Pharmaceuticals

2.9.1 Business Overview

2.9.2 Erectile Dysfunction Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Endo Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.10 Futura Medical

2.10.1 Business Overview

2.10.2 Erectile Dysfunction Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Futura Medical Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.11 Meda Pharmaceuticals

2.11.1 Business Overview

2.11.2 Erectile Dysfunction Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Meda Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.12 Promedon

2.12.1 Business Overview

2.12.2 Erectile Dysfunction Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Promedon Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.13 SK Chemical

2.13.1 Business Overview

2.13.2 Erectile Dysfunction Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 SK Chemical Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.14 Teva Pharmaceuticals

2.14.1 Business Overview

2.14.2 Erectile Dysfunction Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Teva Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.15 Vivus

2.15.1 Business Overview

2.15.2 Erectile Dysfunction Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Vivus Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

2.16 Zephyr Surgical Implants (ZSI)

2.16.1 Business Overview

2.16.2 Erectile Dysfunction Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Zephyr Surgical Implants (ZSI) Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

3 Global Erectile Dysfunction Market Competition, by Players

3.1 Global Erectile Dysfunction Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Erectile Dysfunction Players Market Share

3.2.2 Top 10 Erectile Dysfunction Players Market Share

3.3 Market Competition Trend

4 Global Erectile Dysfunction Market Size by Regions

4.1 Global Erectile Dysfunction Revenue and Market Share by Regions

4.2 North America Erectile Dysfunction Revenue and Growth Rate (2013-2018)

4.3 Europe Erectile Dysfunction Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Erectile Dysfunction Revenue and Growth Rate (2013-2018)

4.5 South America Erectile Dysfunction Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Erectile Dysfunction Revenue and Growth Rate (2013-2018)

5 North America Erectile Dysfunction Revenue by Countries

5.1 North America Erectile Dysfunction Revenue by Countries (2013-2018)

5.2 USA Erectile Dysfunction Revenue and Growth Rate (2013-2018)

5.3 Canada Erectile Dysfunction Revenue and Growth Rate (2013-2018)

5.4 Mexico Erectile Dysfunction Revenue and Growth Rate (2013-2018)

6 Europe Erectile Dysfunction Revenue by Countries

6.1 Europe Erectile Dysfunction Revenue by Countries (2013-2018)

6.2 Germany Erectile Dysfunction Revenue and Growth Rate (2013-2018)

6.3 UK Erectile Dysfunction Revenue and Growth Rate (2013-2018)

6.4 France Erectile Dysfunction Revenue and Growth Rate (2013-2018)

6.5 Russia Erectile Dysfunction Revenue and Growth Rate (2013-2018)

6.6 Italy Erectile Dysfunction Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Erectile Dysfunction Revenue by Countries

7.1 Asia-Pacific Erectile Dysfunction Revenue by Countries (2013-2018)

7.2 China Erectile Dysfunction Revenue and Growth Rate (2013-2018)

7.3 Japan Erectile Dysfunction Revenue and Growth Rate (2013-2018)

7.4 Korea Erectile Dysfunction Revenue and Growth Rate (2013-2018)

7.5 India Erectile Dysfunction Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Erectile Dysfunction Revenue and Growth Rate (2013-2018)

8 South America Erectile Dysfunction Revenue by Countries

8.1 South America Erectile Dysfunction Revenue by Countries (2013-2018)

8.2 Brazil Erectile Dysfunction Revenue and Growth Rate (2013-2018)

8.3 Argentina Erectile Dysfunction Revenue and Growth Rate (2013-2018)

8.4 Colombia Erectile Dysfunction Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Erectile Dysfunction by Countries

9.1 Middle East and Africa Erectile Dysfunction Revenue by Countries (2013-2018)

9.2 Saudi Arabia Erectile Dysfunction Revenue and Growth Rate (2013-2018)

9.3 UAE Erectile Dysfunction Revenue and Growth Rate (2013-2018)

9.4 Egypt Erectile Dysfunction Revenue and Growth Rate (2013-2018)

9.5 Nigeria Erectile Dysfunction Revenue and Growth Rate (2013-2018)

9.6 South Africa Erectile Dysfunction Revenue and Growth Rate (2013-2018)

10 Global Erectile Dysfunction Market Segment by Type

10.1 Global Erectile Dysfunction Revenue and Market Share by Type (2013-2018)

10.2 Global Erectile Dysfunction Market Forecast by Type (2018-2023)

10.3 ED Drugs Revenue Growth Rate (2013-2023)

10.4 ED Devices Revenue Growth Rate (2013-2023)

11 Global Erectile Dysfunction Market Segment by Application

11.1 Global Erectile Dysfunction Revenue Market Share by Application (2013-2018)

11.2 Erectile Dysfunction Market Forecast by Application (2018-2023)

11.3 Congenital Patients Revenue Growth (2013-2018)

11.4 Pathological Patients Revenue Growth (2013-2018)

12 Global Erectile Dysfunction Market Size Forecast (2018-2023)

12.1 Global Erectile Dysfunction Market Size Forecast (2018-2023)

12.2 Global Erectile Dysfunction Market Forecast by Regions (2018-2023)

12.3 North America Erectile Dysfunction Revenue Market Forecast (2018-2023)

12.4 Europe Erectile Dysfunction Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Erectile Dysfunction Revenue Market Forecast (2018-2023)

12.6 South America Erectile Dysfunction Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Erectile Dysfunction Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Erectile Dysfunction Picture

Table Product Specifications of Erectile Dysfunction

Table Global Erectile Dysfunction and Revenue (Million USD) Market Split by Product Type

Figure Global Erectile Dysfunction Revenue Market Share by Types in 2017

Figure ED Drugs Picture

Figure ED Devices Picture

Table Global Erectile Dysfunction Revenue (Million USD) by Application (2013-2023)

Figure Erectile Dysfunction Revenue Market Share by Applications in 2017

Figure Congenital Patients Picture

Figure Pathological Patients Picture

Table Global Market Erectile Dysfunction Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Erectile Dysfunction Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Erectile Dysfunction Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Erectile Dysfunction Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Erectile Dysfunction Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Erectile Dysfunction Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Erectile Dysfunction Revenue (Million USD) and Growth Rate (2013-2023)

Table Eli Lilly Basic Information, Manufacturing Base and Competitors

Table Eli Lilly Erectile Dysfunction Type and Applications

Table Eli Lilly Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Erectile Dysfunction Type and Applications

Table Pfizer Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Bayer Basic Information, Manufacturing Base and Competitors

Table Bayer Erectile Dysfunction Type and Applications

Table Bayer Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Boston Scientific Basic Information, Manufacturing Base and Competitors

Table Boston Scientific Erectile Dysfunction Type and Applications

Table Boston Scientific Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Coloplast Basic Information, Manufacturing Base and Competitors

Table Coloplast Erectile Dysfunction Type and Applications

Table Coloplast Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Apricus Biosciences Basic Information, Manufacturing Base and Competitors

Table Apricus Biosciences Erectile Dysfunction Type and Applications

Table Apricus Biosciences Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Cristalia Produtos Quimicos Farmaceuticos Basic Information, Manufacturing Base and Competitors

Table Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Type and Applications

Table Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Dong-A Socio Basic Information, Manufacturing Base and Competitors

Table Dong-A Socio Erectile Dysfunction Type and Applications

Table Dong-A Socio Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Endo Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Endo Pharmaceuticals Erectile Dysfunction Type and Applications

Table Endo Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Futura Medical Basic Information, Manufacturing Base and Competitors

Table Futura Medical Erectile Dysfunction Type and Applications

Table Futura Medical Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Meda Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Meda Pharmaceuticals Erectile Dysfunction Type and Applications

Table Meda Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Promedon Basic Information, Manufacturing Base and Competitors

Table Promedon Erectile Dysfunction Type and Applications

Table Promedon Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table SK Chemical Basic Information, Manufacturing Base and Competitors

Table SK Chemical Erectile Dysfunction Type and Applications

Table SK Chemical Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceuticals Erectile Dysfunction Type and Applications

Table Teva Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Vivus Basic Information, Manufacturing Base and Competitors

Table Vivus Erectile Dysfunction Type and Applications

Table Vivus Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Zephyr Surgical Implants (ZSI) Basic Information, Manufacturing Base and Competitors

Table Zephyr Surgical Implants (ZSI) Erectile Dysfunction Type and Applications

Table Zephyr Surgical Implants (ZSI) Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)

Table Global Erectile Dysfunction Revenue (Million USD) by Players (2013-2018)

Table Global Erectile Dysfunction Revenue Share by Players (2013-2018)

Figure Global Erectile Dysfunction Revenue Share by Players in 2016

Figure Global Erectile Dysfunction Revenue Share by Players in 2017

Figure Global Top 5 Players Erectile Dysfunction Revenue Market Share in 2017

Figure Global Top 10 Players Erectile Dysfunction Revenue Market Share in 2017

Figure Global Erectile Dysfunction Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Erectile Dysfunction Revenue (Million USD) by Regions (2013-2018)

Table Global Erectile Dysfunction Revenue Market Share by Regions (2013-2018)

Figure Global Erectile Dysfunction Revenue Market Share by Regions (2013-2018)

Figure Global Erectile Dysfunction Revenue Market Share by Regions in 2017

Figure North America Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure Europe Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure South America Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Table North America Erectile Dysfunction Revenue by Countries (2013-2018)

Table North America Erectile Dysfunction Revenue Market Share by Countries (2013-2018)

Figure North America Erectile Dysfunction Revenue Market Share by Countries (2013-2018)

Figure North America Erectile Dysfunction Revenue Market Share by Countries in 2017

Figure USA Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure Canada Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure Mexico Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Table Europe Erectile Dysfunction Revenue (Million USD) by Countries (2013-2018)

Figure Europe Erectile Dysfunction Revenue Market Share by Countries (2013-2018)

Figure Europe Erectile Dysfunction Revenue Market Share by Countries in 2017

Figure Germany Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure UK Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure France Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure Russia Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure Italy Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Erectile Dysfunction Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Erectile Dysfunction Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Erectile Dysfunction Revenue Market Share by Countries in 2017

Figure China Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure Japan Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure Korea Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure India Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Table South America Erectile Dysfunction Revenue by Countries (2013-2018)

Table South America Erectile Dysfunction Revenue Market Share by Countries (2013-2018)

Figure South America Erectile Dysfunction Revenue Market Share by Countries (2013-2018)

Figure South America Erectile Dysfunction Revenue Market Share by Countries in 2017

Figure Brazil Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure Argentina Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure Colombia Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Erectile Dysfunction Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Erectile Dysfunction Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Erectile Dysfunction Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Erectile Dysfunction Revenue Market Share by Countries in 2017

Figure Saudi Arabia Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure UAE Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure Egypt Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure Nigeria Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Figure South Africa Erectile Dysfunction Revenue and Growth Rate (2013-2018)

Table Global Erectile Dysfunction Revenue (Million USD) by Type (2013-2018)

Table Global Erectile Dysfunction Revenue Share by Type (2013-2018)

Figure Global Erectile Dysfunction Revenue Share by Type (2013-2018)

Figure Global Erectile Dysfunction Revenue Share by Type in 2017

Table Global Erectile Dysfunction Revenue Forecast by Type (2018-2023)

Figure Global Erectile Dysfunction Market Share Forecast by Type (2018-2023)

Figure Global ED Drugs Revenue Growth Rate (2013-2018)

Figure Global ED Devices Revenue Growth Rate (2013-2018)

Table Global Erectile Dysfunction Revenue by Application (2013-2018)

Table Global Erectile Dysfunction Revenue Share by Application (2013-2018)

Figure Global Erectile Dysfunction Revenue Share by Application (2013-2018)

Figure Global Erectile Dysfunction Revenue Share by Application in 2017

Table Global Erectile Dysfunction Revenue Forecast by Application (2018-2023)

Figure Global Erectile Dysfunction Market Share Forecast by Application (2018-2023)

Figure Global Congenital Patients Revenue Growth Rate (2013-2018)

Figure Global Pathological Patients Revenue Growth Rate (2013-2018)

Figure Global Erectile Dysfunction Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Erectile Dysfunction Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Erectile Dysfunction Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Erectile Dysfunction Revenue Market Forecast (2018-2023)

Figure Europe Erectile Dysfunction Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Erectile Dysfunction Revenue Market Forecast (2018-2023)

Figure South America Erectile Dysfunction Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Erectile Dysfunction Revenue Market Forecast (2018-2023)



【レポートのキーワード】

勃起不全、ED薬、EDデバイス、先天性患者、病理学的患者

★調査レポート[勃起不全の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8102235)販売に関する免責事項を必ずご確認ください。
★調査レポート[勃起不全の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆